ALNY · Alnylam Pharmaceuticals, Inc. · Analyst Estimates
$246.74
-7.33 (-2.89%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$34.17B
Shares
133.81M
Volume · Sep 30
1.04M
Avg daily vol (3M)
1.8M
Analyst Estimates
Compare analyst forecasts for Alnylam Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-30 16:09 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
7.77
|
8.83414
|
10.70923
|
— |
8.91542
|
8.94772
|
8.84542
|
9.42061
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
14
|
— | — | — | — |
10
|
0
|
5
|
1
|
|
Revenue
USD
Publication date not stated |
5332300000
|
5481586470
|
5766000000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
26
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
8.63
|
12.42218
|
17.73594
|
— |
12.58719
|
12.72538
|
12.47148
|
13.57404
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
14
|
— | — | — | — |
11
|
0
|
4
|
1
|
|
Revenue
USD
Publication date not stated |
6140000000
|
6943641870
|
7954700000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
26
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.94
|
2.31056
|
3.44558
|
— |
2.31537
|
2.31537
|
2.31537
|
2.43515
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
14
|
— | — | — | — |
11
|
10
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
1391534390
|
1439266530
|
1491763000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
20
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
1.72
|
2.70689
|
3.43203
|
— |
2.78264
|
2.75907
|
2.71335
|
2.85364
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
14
|
— | — | — | — |
9
|
8
|
5
|
5
|
|
Revenue
USD
Publication date not stated |
1413100000
|
1566761210
|
1700000000
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
20
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
20 filings
16 filers
Visit website
Investor relations